GE Healthcare Said to Be Close to Acquiring Abbott Diagnostics In Further Dx Reorganization | GenomeWeb
NEW YORK (GenomeWeb News) — GE Healthcare may soon acquire Abbott Diagnostics in an attempt to fatten its molecular diagnostics play, according to news reports this morning.

GE has been eyeing the in vitro diagnostic space since it acquired Amersham in 2004, and the Abbott business could offer it a substantial position in that market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.